Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1969 Jan 11;1(5636):82–84. doi: 10.1136/bmj.1.5636.82

Intermittent Chemotherapy for Tuberculosis in an Urban Community

Graham Poole, Peter Stradling
PMCID: PMC1981997  PMID: 5761830

Abstract

A regimen designed for effective foolproof antituberculosis treatment, acceptable on a routine basis, was applied to all patients newly diagnosed at the Chest Clinic, Hammersmith Hospital, in 1963, 1964, and 1965. During the first three months of treatment patients received daily (six days a week) streptomycin 0.75 g. plus isoniazid 300 mg. plus sodium para-aminosalicylate (P.A.S.) 12 g. The P.A.S. was usually stopped when bacterial sensitivity reports made this possible. For a further 15 months streptomycin 1 g. plus isoniazid 600 mg. was given on three alternate days each week to complete a total of 18 months' treatment.

Of the total of 140 patients (66% sputum-positive) 112 (80%) completed the planned 18 months with intermittent streptomycin plus isoniazid and a further eight completed treatment on alternative regimens (a total of 85%). The equivalent figures for one year are 88% and 94%. Excellent clinical and radiological results, together with sputum conversion, were achieved in 138 of the 140 patients (99%). Only two patients were lost from surveillance, because of failure to co-operate, before quiescence was obtained.

It is concluded that the total efficiency of supervised intermittent treatment is greater than that of unsupervised daily regimens. Since 100% arrest of tuberculosis is possible with co-operative patients, less should not be accepted in developed countries.

Full text

PDF
82

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DIXON W. M., STRADLING P., WOOTTON I. D. Outpatient P.A.S. therapy. Lancet. 1957 Nov 2;273(7001):871–872. doi: 10.1016/s0140-6736(57)90006-5. [DOI] [PubMed] [Google Scholar]
  2. JOHNSTON R. N., SMITH D. H., RITCHIE R. T., LOCKHART W. PROLONGED STREPTOMYCIN AND ISONIAZID FOR PULMONARY TUBERCULOSIS. Br Med J. 1964 Jun 27;1(5399):1679–1683. doi: 10.1136/bmj.1.5399.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. LEHMANN J. [Chemical and experimental bases of PAS therapy]. Wien Med Wochenschr. 1961 Nov 25;111:803–805. [PubMed] [Google Scholar]
  4. MITCHISON D. A. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT. Br Med J. 1965 May 22;1(5446):1333–1340. [PMC free article] [PubMed] [Google Scholar]
  5. Nicholson W. A. Collection of unwanted drugs from private homes. Br Med J. 1967 Sep 16;3(5567):730–731. doi: 10.1136/bmj.3.5567.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. POOLE G., STRADLING P. Chemotherapeutic pitfalls in the treatment of tuberculosis. Br Med J. 1960 Jan 16;1(5167):161–165. doi: 10.1136/bmj.1.5167.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. PRESTON D. F., MILLER F. L. THE TUBERCULOSIS OUTPATIENTS DEFECTION FROM THERAPY. Am J Med Sci. 1964 Jan;247:21–25. doi: 10.1097/00000441-196401000-00002. [DOI] [PubMed] [Google Scholar]
  8. Poole G., Stradling P. The long-term use of intermittent streptomycin plus isoniazid in the treatment of tuberculosis. Tubercle. 1965 Sep;46(3):290–293. doi: 10.1016/s0041-3879(65)80026-5. [DOI] [PubMed] [Google Scholar]
  9. RISKA N. PAS therapy with a daily unfractionated dose. Acta Tuberc Scand. 1959;37:104–111. [PubMed] [Google Scholar]
  10. SIMPSON J. M. Simple tests for the detection of urinary PAS. Tubercle. 1956 Oct;37(5):333–340. doi: 10.1016/s0041-3879(56)80079-2. [DOI] [PubMed] [Google Scholar]
  11. WYNN-WILLIAMS N., ARRIS M. On omitting PAS. Tubercle. 1958 Jun;39(3):138–142. doi: 10.1016/s0041-3879(58)80040-9. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES